Elekta, a Stockholm-based clinical solutions company, announced today that its iViewDose software has received 501(k) clearance from the FDA.
According to the company, the new dosimetry software provides an efficient solution for the detection of radiotherapy errors, potentially detecting more errors than other alternative pretreatment verification methods.
The software, a joint project from Elekta and The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), also received financing from Netherlands granting body Technology Foundation STW.
“iViewDose can detect several errors that can’t be detected with pre-treatment checks, such as phantoms in combination with an ionization chamber or diode arrays,” Igor Olaciregui-Ruiz, product developer at NKI-AVL, said in a press release. “These error sources include variations in patient anatomy or patient position and the effect of immobilization devices on dose calculation and delivery among other types of errors.”